Janus Henderson Group PLC Meridian Bioscience Inc Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$31.15 - $33.39 $3.11 Million - $3.33 Million
99,714 Added 31.27%
418,615 $13.9 Million
Q3 2022

Nov 14, 2022
BUY
$30.9 - $33.55 $8.47 Million - $9.19 Million
274,012 Added 610.42%
318,901 $10.1 Million
Q2 2022

Aug 15, 2022
SELL
$23.75 - $31.69 $172,876 - $230,671
-7,279 Reduced 13.95%
44,889 $1.37 Million
Q1 2022

May 16, 2022
BUY
$19.97 - $26.94 $275,705 - $371,933
13,806 Added 35.99%
52,168 $1.35 Million
Q4 2021

Feb 14, 2022
BUY
$17.46 - $21.61 $669,800 - $829,002
38,362 New
38,362 $782,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email